McCarter & English LLP, a prestigious US law firm, recently asked a New Jersey state court to reject a plea from a biotech company. The company sought to modify its complaint alleging the legal firm of malpractice. McCarter & English argues that the proposed changes would necessitate new discovery and that the allotted timeline for amendments has already expired. The request for amendments included fresh malpractice claims against the firm, which the biotech company believes are crucial to its case.
Repercussions of the court’s decision could be significant for both parties. For McCarter & English, avoiding new discovery could mean circumventing potentially damaging revelations. If the biotech company’s request is denied, it could lose out on exploring new avenues to build a stronger case. The verdict will inevitably impact the groups’ respective legal strategies going forward.
For more detailed information, please refer to the original reporting on the matter by Law360.